Bringing a new therapy to market in the US has never been more high-stakes. With growing pricing pressure, shifting policy, complex reimbursement pathways and rising expectations for speed, access and impact, even the most robust launch strategies can fall short at the point of execution.
Pharma Launch Excellence Summit US brings together cross-functional leaders from across commercial, medical, access, supply and operations to tackle what actually determines launch success—alignment, adaptability and execution at scale.
From early planning through to post-launch performance, #PHLEXUS is where launch leaders come to share what’s working, what’s not, and how to execute with confidence in an increasingly complex landscape.
Everyone has a launch strategy. Few deliver a launch that performs. Across two days in Boston, explore how to...
Unlike traditional launch events, this is not focused on theory or frameworks in isolation. Designed specifically for the US market, the summit addresses the operational, organizational and commercial challenges that arise when bringing therapies to market in a fragmented, fast-moving environment—where assumptions change, timelines compress, and execution determines success.
Join senior leaders responsible for bringing therapies to market across:
As rising R&D costs, restricted access to healthcare professionals, and intensifying competition continue to reshape the market, pharma leaders are under increasing pressure to deliver successful launches.
This in‑depth 60+ page report explores the key challenges, trends, and best practices shaping the future of pharma launch strategy.
Download your complimentary copy to equip your team with the insights needed to launch smarter, faster, and more effectively.
Find out how you could be part of Pharmaceutical Launch Excellence Summit US movement or for any questions at all, please contact us below: